In Vietnam, the combination of NS5A / NS5B drugs is officially circulated, which has very few studies assessing the therapeutic efficacy and drug tolerance of these drugs in hepatitis C On the other hand, there are also fewer data on treatment efficiency of patients with genotype 1.6 in the world.